Clinical trial
Single-center, Randomized, Open-label, Parallel-group Study to Characterize Renin-angiotensin-system (RAS) Peptide Profiles Before and After Treatment Initiation With Different Antihypertensive Drug-classes in Patients With Treatment-naive Arterial Hypertension
NCT02449811 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Single-center, Randomized, Open-label, Parallel-group Study to Characterize Renin-angiotensin-system (RAS) Peptide Profiles Before and After Treatment Initiation With Different Antihypertensive Drug-classes in Patients With Treatment-naive Arterial Hypertension
- Lead sponsor
- Insel Gruppe AG, University Hospital Bern
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- November 30, 2018
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.